平博

Social Responsibility

In 2018 EHS investment continued to increase, exceeding 54 million RMB,
"Diabetic Care" has served more than 1 million doctors and patients.

Corporate Citizen

Wanbang Biopharma has incorporated social responsibility into the long-term strategy of corporate development.
In the process of business development, Wanbang Biopharma has always been grateful.
Strive to be a company that satisfies society, government, employees and shareholders.
Explore More

Diabetic Care Family

Bang Program

School-enterprise Cooperation

Xingbang Health Family

Rural Doctors

Earthquake Relief

Public Walfare

Explore More